Skip to content
Home/GPs/Clarendon Fund Managers
DetailCard
Clarendon Fund Managers

Clarendon Fund Managers

Belfast, United Kingdom·Founded 1998··clarendon-fm.co.uk

Clarendon Fund Managers is a Belfast-based venture and development-capital manager that runs the Northern Ireland regional equity funds appointed by Invest NI and the British Business Bank, including Co-Fund NI, the GBP 39 million Co-Fund NI III and the GBP 33 million equity sleeve of the GBP 70 million Investment Fund for Northern Ireland. Incorporated in 1998 and investing since 2001, it has backed more than 100 Northern Irish SMEs across over 350 funding rounds. The firm is authorised and regulated by the UK Financial Conduct Authority under firm reference number 224974.

AUM
€165M
Funds
3
vintages 2012–2024
Portfolio
54
Exits
11

Clarendon Fund Managers is a Belfast venture capital firm with €165M AUM, 54 active companies and 11 exits.

Key takeaways
  • ·6 exits in the last 5 years · consistent DPI cadence.
  • ·Average hold across 10 realized deals: 5 years.
  • ·Fund cadence: ~6Y between vintages · last raise 2024.

Sector breakdown

65 companies
SaaS
13 · 20%
Biotech
8 · 12%
MedTech
6 · 9%
Consumer
6 · 9%
ClimateTech
5 · 8%
Cybersecurity
5 · 8%
HealthTech
5 · 8%
Data & Analytics
4 · 6%

Geography breakdown

6 geographies
UK
58 · 89%
Belfast, Northern Ireland, UK
3 · 5%
Ballymena, Northern Ireland, UK
1 · 2%
Derry/Londonderry, Northern Ireland, United Kingdom
1 · 2%
Newcastle, Northern Ireland, United Kingdom
1 · 2%
Belfast, Northern Ireland, United Kingdom
1 · 2%

Key facts

HQBelfast, United Kingdom
Founded1998
Employees11+

Recent exits

Clarendon Fund Managers sold CADshare to Documoto (Valstone) in 2026.

Reform RX

Clarendon Fund Managers sold Reform RX to iFIT in 2025 after 1 year.

AuditComply

Clarendon Fund Managers sold AuditComply to Nulogy in 2025 after 10 years.

Clarendon Fund Managers sold Surgery Hero to Sword Health in 2025 after 3 years.

Partners

Damien CallaghanChairman
Neil SimmsFinance Director and Investment Director
Jim CurranInvestment Director
Brian CummingsInvestment Director
Stuart GaffikinInvestment Director

Coverage notes

3 funds tracked, 65 portfolio companies (54 active · 11 realized). Verified weekly from public filings and deal announcements.

Investment team

Senior partners. Hand-checked from public filings and the firm's own site.

Damien Callaghan
Chairman
Neil Simms
Finance Director and Investment Director
Jim Curran
Investment Director
Brian Cummings
Investment Director
Stuart Gaffikin
Investment Director
Claudine Owens
Senior Investment Manager

Funds & portfolio

Every fund Clarendon Fund Managers has raised, with its portfolio companies. Hand-checked from public filings.

3 funds
Co-Fund NI III
VC2024€46M13 assets1 exits

Unrealized

13 held
CompanyEntry
AntennaWare
TMT · Belfast, Northern Ireland, UK
–
Changeover Technologies
ClimateTech · Belfast, Northern Ireland, UK
2015
CIGA Healthcare
MedTech · Ballymena, Northern Ireland, UK
2017
Dia Beta Labs
Biotech · UK
2025
Fluid Focus
SaaS · UK
2025
Ilimex
ClimateTech · UK
2025
IncluTech
Software · UK
2025
LumenStream
ClimateTech · UK
2025
Respiratory Analytics Ltd (aflo)
MedTech · Derry/Londonderry, Northern Ireland, United Kingdom
–
Senergy Innovations
ClimateTech · UK
2025
Stimoxygen
Biotech · UK
2025
TeamFeePay
SaaS · UK
2026
The Blinky Company
Consumer · Newcastle, Northern Ireland, United Kingdom
2021

Realized

1 exit
CompanyEntryExitTypeBuyerMOIC
CADshare
SaaS · Belfast, Northern Ireland, UK
–2026Trade SaleDocumoto (Valstone)–
Investment Fund for Northern Ireland
Growth2024€39M6 assets1 exits

Unrealized

6 held
CompanyEntry
Automated Intelligence
Software · Belfast, Northern Ireland, United Kingdom
–
Cirdan Imaging
MedTech · UK
2024
Cocktail Keg Company
Consumer · UK
2024
Inqdata
Data & Analytics · UK
2024
Needi
E-commerce · UK
2024
Stora
SaaS · UK
2024

Realized

1 exit
CompanyEntryExitTypeBuyerMOIC
Reform RX
Consumer · UK
20242025Trade SaleiFIT–
Co-Fund NI
VC2012€55M35 assets9 exits

Unrealized

35 held
CompanyEntry
3DEO
Data & Analytics · UK
2021
Adoreboard
AI/ML · UK
2019
Ampliphae
Cybersecurity · UK
2016
Amply
Biotech · UK
2022
Analytics Engines
Data & Analytics · UK
2016
Angoka
Cybersecurity · UK
2022
Aramune Technologies
Biotech · UK
2022
axial3D
MedTech · UK
2019
B-Secur
Cybersecurity · UK
2020
Bluesona
Software · UK
2019
Boatyard
Consumer · UK
2020
Broker IQ
InsurTech · UK
2021
Bubblebum
Consumer · UK
2012
Cumulus Neuroscience
HealthTech · UK
2017
CV6 Therapeutics
Biotech · UK
2022
Datactics
Data & Analytics · UK
2021
GenoME Diagnostics
Biotech · UK
2023
Haru
Consumer · UK
2021
Kinsetsu
SaaS · UK
2023
Life Pass by Mountain Technologies
SaaS · UK
2020
Locate a Locum
HealthTech · UK
2019
LoyalBe
Fintech · UK
2021
Modern Democracy
SaaS · UK
2022
Neurovalens
MedTech · UK
2020
Pitchbooking
SaaS · UK
2019
Rock Extraction
Industrials · UK
2022
Salt Communications
Cybersecurity · UK
2016
Sonrai Analytics
HealthTech · UK
2020
StormHarvester
ClimateTech · UK
2020
SureCert
HR Tech · UK
2018
SustainIQ
SaaS · UK
2021
Thrive
Education · UK
2020
VascVersa
Biotech · UK
2021
Viper Clip
Construction · UK
2020
Zymplify
SaaS · UK
2019

Realized

9 exits
CompanyEntryExitTypeBuyerMOIC
AuditComply
SaaS · UK
20152025Trade SaleNulogy–
Diaceutics
HealthTech · UK
20152019IPO––
Fusion Antibodies
Biotech · UK
20132017IPO––
Ingresso
SaaS · UK
20132017Trade SaleAccesso Technology Group–
PathXL
MedTech · UK
20122016Trade SaleRoyal Philips–
Repstor
SaaS · UK
20132021Trade SaleIntapp–
Surgery Hero
HealthTech · UK
20222025Trade SaleSword Health–
Titan IC Systems
Cybersecurity · UK
20152020Trade SaleMellanox Technologies–
Tribe Technology
Industrials · UK
20202023IPO––

About Clarendon Fund Managers

Clarendon Fund Managers is Northern Ireland's longest-running co-investment venture capital manager with approximately £94 million in regional VC funds as of December 2024 (Co-Fund NI £47.3 million, IFNI Clarendon Equity Finance as part of the £70 million Investment Fund for Northern Ireland), headquartered in Belfast at Craig Plaza, Fountain Street. The firm was founded in 2001 and operates as an independent fund manager deploying public and agency capital from Invest NI, the British Business Bank and Innovation Ulster, having backed 100-plus companies since 2001.

Investment thesis

Clarendon Fund Managers deploys capital through approximately four to five funds (Co-Fund NI I-III, IFNI Clarendon Equity Finance), targeting equity co-investment alongside business angels and syndicates with initial cheques of approximately £50k-£250k (Co-Fund) up to £5 million (IFNI), plus follow-on support. Sector focus spans software, compliance and regtech, healthtech and biosecurity, edtech, tech for good and consumer tech (broadly sector-agnostic). Geographic deployment is Northern Ireland. The platform pairs public funds with local angel capital.

Recent activity

Recent realised exits include compliance and manufacturing software (2025). Recent acquisitions include an edtech and payments follow-on (2026), air-sterilisation and biosecurity tech (2025) and accessibility tech-for-good software (2025). The platform continues active deployment across the Northern Ireland co-investment mandate.

Frequently asked questions

What investment strategy does Clarendon Fund Managers focus on?
Clarendon Fund Managers focuses on VC, Growth strategies in the private equity space.
How many portfolio companies does Clarendon Fund Managers have?
Clarendon Fund Managers has 54 active portfolio companies and 11 completed exits and 3 funds tracked on GP Intel.
Where is Clarendon Fund Managers headquartered?
Clarendon Fund Managers is headquartered in Belfast, United Kingdom.
What is Clarendon Fund Managers's assets under management?
Clarendon Fund Managers manages approximately €165M in assets under management.
When was Clarendon Fund Managers founded?
Clarendon Fund Managers was founded in 1998.
What sectors does Clarendon Fund Managers invest in?
Clarendon Fund Managers invests across Healthcare, Software, TMT, Industrials.
What are Clarendon Fund Managers's recent exits?
Recent realized exits by Clarendon Fund Managers include: CADshare (2026) to Documoto (Valstone); Reform RX (2025) to iFIT; AuditComply (2025) to Nulogy; Surgery Hero (2025) to Sword Health; Repstor (2021) to Intapp; Titan IC Systems (2020) to Mellanox Technologies; Ingresso (2017) to Accesso Technology Group; PathXL (2016) to Royal Philips.
Look up another firm or company
Last updated July 2026 · Sourced from public filings · Report an issue